1. Zecong Xiao, Zhenwei Su, Shisong Han, Jinsheng Huang, Liteng Lin, Xintao Shuai , Dual
pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF- κ B inhibitor for
antitumor immunotherapy. Science Advances(2020).
2. Zecong Xiao, Yujun Cai, Xiaobin Wang, Lijun Hu, Minzhao Lin, Kangshun Zhu, Yong Wang,
Xintao Shuai, Nanodrug simultaneously regulates stromal extracellular matrix and glucose metabolism for
effective immunotherapy against orthotopic pancreatic cancer. Nano Today (2022).
3. Zecong Xiao, Tan Li, Xinyao Zheng, Liteng Lin, Xiaobin Wang, Bo Li, Jingjun Huang, Yong
Wang, Xintao Shuai, Kangshun Zhu, Nanodrug enhances post-ablation immunotherapy of hepatocellular
carcinoma via promoting dendritic cell maturation and antigen presentation. Bioactive materials(2022).
4. Zecong Xiao, Xinyao Zheng, Ying An, Kangning Wang, Junwen Zhang, Huacheng He, Jiang Wu,
Zwitterionic hydrogel for sustained release of growth factors to enhance wound healing. Biomaterials
Science(2020).
5. Shaohui Deng, Shiyin Wang, Zecong Xiao*, Du Cheng*, Unprotonatable and ROS-sensitive
nanocarrier for NIR spatially activated siRNA therapy with synergistic drug effect. Small(2022).
代表性成果:
1. 国家自然科学基金青年科学基金项目(82102194):纳米药物功能化 T 细胞提高高间质压肿
瘤免疫治疗效果的研究; 30 万; 2021 年 10 月-2023 年 4 月。(主持)
2. 中国博士后科学基金面上资助(一等资助)(2020M680119): 基于基质清除的纳米输送策
略高效促进肿瘤内 T 细胞浸润提高乳腺癌免疫治疗效果;12 万;2020 年-2022 年。(主持)
3.
广东省基础与应用基础研究基金项目区域联合基金
-
青年基金项目(
2020A1515111206
):肿瘤
浸润淋巴细胞介导的药物高效输送与渗透体系实现胰腺癌高效免疫治疗的研究;
10
万;
2020
年
10
月
-2023 年 9 月。(主持)